Cancer Nutrition HQ
I break down a new large clinical trial that examined weight loss outcomes in women with stage II–III breast cancer after treatment. We explore what the year-long lifestyle intervention included, how much weight participants lost, and why average numbers don’t tell the full story. I discuss differences in weight loss by menopausal status and race, common frustrations survivors experience, and where GLP-1 medications may fit into weight management after breast cancer. Ligibel JA, Ballman KV, McCall L, et al. Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial. JAMA Oncol. 2025;11(10):1194-1203. doi:10.1001/jamaoncol.2025.2738 Send us Fan Mail [https://www.buzzsprout.com/2518041/fan_mail/new] Follow me on Instagram @cancernutritionhq [https://www.instagram.com/cancernutritionhq/] www.cancernutritionhq.com [https://cancernutritionhq.com/]
20 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Cancer Nutrition HQ!